ThinkSono GmbH has secured $6 million in funding to expand its AI-driven DVT detection software and accelerate its U.S. market entry.
Information on the Target
ThinkSono GmbH, founded in 2016, is a pioneering MedTech startup based in Potsdam, Germany. The company has developed the world's first artificial intelligence (AI)-powered real-time ultrasound software that enables medical personnel, even without prior ultrasound training, to conduct scans for Deep Venous Thrombosis (DVT). This innovative technology addresses a significant unmet medical need for enhanced DVT detection worldwide. Furthermore, ThinkSono is actively creating training solutions for other AI ultrasound applications to improve access to ultrasound imaging and qualify untrained health personnel for essential ultrasound examinations. Their DVT solution has been tested in hospitals across the UK and the EU and is now being introduced in the United States.
Industry Overview in Germany
The healthcare industry in Germany is renowned for its advanced technology and commitment to innovation. As one of Europe's largest and most diversified healthcare markets, Germany offers a landscape ripe for MedTech advancements. The demand for efficient and effective medical solutions, particularly in areas such as diagnostics and patient care, is on the rise.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Within this context, the MedTech sector is increasingly driven by technological advancements, particularly in AI and machine learning. These innovations not only enhance diagnostic capabilities but al
Similar Deals
Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, Wellington Partners, Bayern Kapital, High-Tech Gründerfonds, PhiFund Ventures → SciRhom GmbH
2024
Brandenburg Kapital
invested in
ThinkSono
in 2025
in a Series A deal
Disclosed details
Transaction Size: $6M